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Abstract: This paper articulates in broad terms a model bioscience 
environment and its primary constituent parts, which include 
bioscience policy and regulation, technology deployment and 
stakeholder engagement, and science innovation systems.  Then, 
having reference to empirical data generated by the GET: Social 
Values Project, it offers an explanation of how the Argentine 
environment departs from that ideal model.  Finally, focusing on one 
constituent part of the environment – the policy and regulatory space – 
it reports on Argentine stakeholder opinions and desires and what 
these mean for the potential to adopt facilitative regulation in 
Argentina.  It concludes that the Argentine scientific environment is 
sub-optimal and poorly equipped to deal effectively and positively 
with the plurality of ideas that people have for both the trajectory of 
science and its regulation.  It ends with a call for further research 
which broadens the evidence base and thereby facilitates the 
improvement of the social/science environment and its constituent 
parts. 
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There has been a lot of noise from Argentina, both before and since the 2007 
formation of the Ministry of Science, Technology and Innovative Production 
(MOST), about the importance of science both generally and developmentally, and 
there has been some interest from Argentine policymakers and regulators in stem cells 
as a means of building competitiveness in the biosciences,1 where Argentina has 
enjoyed historical success.2  Recent activities have included the following: 
                                                 
∗  Research Fellow, INNOGEN, ESRC Centre for Social and Economic Research on Innovation 
in Genomics, University of Edinburgh, and SCRIPT, AHRC Centre for Research on Intellectual 
Property and Technology Law, University of Edinburgh; Member of the Nova Scotia Bar; BA, Saint 
Mary’s University (1993); LLB, University of New Brunswick (1996); LLM, University of Edinburgh 
(2004).  The author would like to acknowledge and thank the generous support of the ESRC to this 
research. 
1  See P. Smaglik, “Argentina’s Pivotal Moment” (2008) 451 Nature 494-496. 
2  Argentina has had a number of Nobel Laureates in the biosciences, including Bernardo 
Houssay, Luis Leloir, and César Milstein, and some elements of Argentine research have been 
described as close to the ‘frontier’ of international knowledge: see P. Kreimer and M. Lugones, 
“Rowing Against the Tide: Emergence and Consolidation of Molecular Biology in Argentina, 1960-
90” (2002) 7 Science, Technology and Society 285-311. 
 
• promotion of international networks and increasing public funds available to 
sci-tech and bioscience development;3 
 
• formation of the Advisory Commission on Regenerative Medicine and 
Cellular Therapies by the MOST in 2008; 
 
• issuance of governmental press releases calling attention to the benefits of 
biosciences like stem cell research;4 and 
 
• signing of international agreements with specified groups to promote 
scientific innovation and international cooperation.5 
 
Despite these efforts, it remains to be seen whether Argentina can effectively build on 
its achievements and existing strengths and realise international bioscience 
competitiveness in anything other than a peripheral manner.6 
This paper considers one element of the means by which bioscience, and more 
particularly stem cell and regenerative medicine research, can be facilitated and 
enhanced in Argentina, namely the bioscience environment and its constituent parts.  
In doing so, it draws on evidence generated by a project entitled ‘Governing 
Emerging Technologies: Social Values and Stem Cell Regulation in Argentina’ (GET: 
Social Values).7  After outlining the methodology adopted for the empirical research, 
the paper articulates in broad terms a model for a positive bioscience environment and 
its primary constituent parts which can be distilled from this and other evidence.  
Then, having reference to the empirical evidence, it offers an explanation of how the 
Argentine environment departs from that model.  Finally, focusing on one constituent 
part of the environment – the policy and regulatory space – it reports on Argentine 
stakeholder opinions and desires and what they mean for the potential to adopt 




The GET: Social Values Project was designed with the intention of gathering 
qualitative data around key issues of bioscience, and in particular stem cell research 
governance, in Argentina, the objective being to discover stakeholder values relevant 
                                                 
3  J. Niosi and S. Reid, “Biotechnology and Nanotechnology: Science-Based Enabling 
Technologies as Windows of Opportunity for LCDs” (2007) 35 World Development 426-438, and E. 
Trigo and E. Cap, “Ten Years of Genetically Modified Crops in Argentine Agriculture” (2006), 
available at http://www.inta.gov.ar/ies/docs/otrosdoc/resyabst/ten_years.htm [accessed 4 August 2009]. 
4  See Argentine Science and Technology Commission, National Congress, available at 
http://www.mincyt.gov.ar/index.php?contenido=comision_celulas_madre1/ [accessed 3 August 2009], 
and Argentine Advisory Commission on Regenerative Medicine and Cellular Therapies, Ministry of 
Science, Technology and Productive Innovation, available at 
http://www.mincyt.gov.ar/index.php?contenido=comision_celulas_madre1/ [accessed 3 August 2009]. 
5  N. Bar, “El Rating de la Ciencia”, La Nación, 13 May 2009, available at 
http://rcdtx.lanacion.com.ar/nota.asp?nota_id=1127536 [accessed 3 August 2009]. 
6  For more on the traditionally peripheral nature of Argentina’s scientific endeavours, see P. 
Kreimer and M. Lugones, supra, note 2. 
7  Governing Emerging Technologies: Social Values and Stem Cell Regulation in Argentina 
(ESRC Responsive Grant Award No. RES-000-22-2678).  For more on the Project, see  the official 
Project website at http://www.law.ed.ac.uk/ahrc/esrcvaluesproject/index.asp, or go to ESRC Society 
Today at http://www.esrcsocietytoday.ac.uk/. 
to, and objectives for, this science and its governance.  While the data generated by 
the 22 semi-structured interviews cannot be said to represent the Argentine view – the 
subject sample was too narrow and too small for such claims – it captures important 
qualitative evidence of the views of key stakeholders in the field.  Moreover, it has 
been welcomed by relevant stakeholders as an early and important first step in 
examining the social context of bioscience (and stem cell) innovation in Argentina.  It 
has enjoyed the support of the Argentine policymaking community, which has 
facilitated access to some of those actors most interested in, and relevant to, stem cell 
research governance. 
Prior to commencement, the GET: Social Values Project was subject to initial 
institutional ethics review and then funding body ethics evaluation.  Research 
participants were chosen from the medical, scientific, academic, policy, legislative 
and regulatory communities.8  As the project was never intended to be a public 
engagement mechanism, the opinions of the broader general public were not solicited.  
Rather, those originally viewed as most likely to influence the nature and content of 
bioscience and stem cell regulation in Argentina were targeted (ie: Argentine science 
policy elites), for, it was felt, only by targeting those most engaged in the pre-
legislative process could we measure the existence of functional connections between 
values and objectives, on the one hand, and legal outputs (when they emerge), on the 
other. 
Following preliminary desktop research on the regulatory setting,9 semi-
structured interviews lasting 50 to 90 minutes were conducted.  Each interview was, 
with permission, recorded.  Open-ended questions and an informal interview schedule 
were used to encourage participants to speak in their own words about their 
experiences, observations, opinions, and desires.  In some cases, more structured 
information was obtained through questionnaires.  Transcription of the interviews was 
performed within Innogen (one the Principal Investigator’s host institutes) and that 
work was subject to a signed Confidentiality Agreement.  Anonymised transcripts 
were shared between the Principal Investigator (in Edinburgh) and the Collaborating 
Investigator (in Buenos Aires) and have been retained for archiving.  Every line of 
transcription and interviewer notes was coded and analysed for emergent themes, and 
sections relating to those themes were grouped together.  The whole assessment was 
refined through an iterative process, thus enabling different perspectives and 
interpretations to be incorporated.  The quotes used in the present paper were chosen 
as reflective of widely canvassed themes, and are deployed to make particular points 




I. DOING ‘GOOD’ SCIENCE: THE SOCIAL/SCIENCE ENVIRONMENT 
AND ACTOR SPACE 
 
                                                 
8  The investigators interviewed at least one respondent, but often multiple respondents, from 
each of the following categories: cabinet level politician; national congressional member; national 
regulatory agency member; national advisory committee member; medical clinician, medical 
researcher, basic scientist, ethicist, academic lawyer. 
9  See S. Harmon, “Emerging Technologies and Developing Countries: Stem Cell Research (and 
Cloning) Regulation and Argentina” (2008) 8(2) Developing World Bioethics 138-150. 
It is clear from actor-network scholarship,10 and (related) innovation systems 
scholarship,11 that the advancement of science is not realised by any linear or 
straightforward process; it involves a plethora of interdependent public and private 
actors and evolving social networks interacting with each other and with existing 
technologies, and it equally relies on other factors such as laws, rules, norms and 
routines, all feeding essential information into the innovation cycle which, when 
operating properly, generates new knowledge and better products and practices.  
Bearing this in mind, I suggest that the ‘best science’12 is most likely to emerge from 
a dynamic, inclusive and positive/facilitative value-conscious social/science 
environment.  Such an environment is characterised by the ability of diverse 
stakeholders to (safely) advance their ideas of the good life and the just society, and 
their (reasoned) notions of morally defensible science.  A healthy social/science 
environment is richly populated by ‘actors’, ‘artefacts’ and ‘nodes’, and it is 
absolutely reliant on the open exchange of ideas and therefore the co-production (and 
reproduction) of actors, nodes and artefacts, and, ultimately, of scientific knowledge 
and useful products and processes. 
In this model, ‘actors’ are individuals, institutions, organisations and social 
networks; a diverse collection of interested people and entities with overlapping and 
shifting allegiances to actor groups and alliances with actor groups.  Actors generate 
and release, and, in turn, receive information and ideas, thereby helping to shape one 
another and giving content to both the subject matter (here bioscience) and the 
environment. 
‘Artefacts’ are vital structures/scaffolds which link the specific environment to 
other external or related environments, and which, more importantly, serve an 
ongoing shaping/influencing and/or monitoring function within the subject 
environment.  They are designed by humans and, in turn, influence the action and 
imagination of humans through their interaction with each other and with the actors 
(ie: they inscribe their characteristics on the human psyche but are similarly 
influenced and continually reconstituted by human actors).  Artefacts can include (1) 
national (or regional) science policies, including funding policies, and science 
regulation and related legislation, (2) formal and informal national, regional or 
sectoral innovation systems (which implicates the former but also includes industry 
actors, objects, and shapers, and active international collaborations), and (3) existing 
technologies and technical practices.  Ultimately, artefacts contribute to the generation 
of science innovation and to the translation of that innovation into socially useful 
products and practices, each exerting their own influence and limitations.  When the 
social/science environment is healthy, its constituent elements reproduce, mutually 
                                                 
10  See P. Gao, “Using Actor-Network Theory to Analyse Strategy Formulation” (2005) 15 
Information Systems J 255-275, S. Fox, “Communities of Practice, Foucault and Actor-Network 
Theory” (2000) 37 J Management Studies 853-867, A. Prout, “Actor-Network Theory, Technology and 
Medical Sociology: An Illustrative Analysis of the Metered Dose Inhaler” (1996) 18 Sociology of 
Health & Illness 198-219, and more. 
11  See C. Edquist (ed.), Systems of Innovation: Technologies, Institutions and Organisations 
(London: Routledge, 1997), J. Niosi, “National Systems of Innovations are ‘X-Efficient’ (and ‘X-
Effective’): Why Some are Slow Learners” (2002) 31 Research Policy 291-302, F. Malerba, “Sectoral 
Systems of Innovation and Production” (2002) 31 Research Policy 247-264, J. Fagerberg et al. (eds.), 
The Oxford Handbook of Innovation (Oxford: OUP, 2006), C. Lyall, “Changing Boundaries: The Role 
of Policy Networks in the Multi-Level Governance of Science and Innovation in Scotland” (2007) 34 
Science & Public Policy 3-14, and more. 
12  Here ‘best science’ means that science which achieves a balance between efficient 
development and production, socially utility, and public acceptability, all of which will be negotiated 
depending on the particular innovation . 
modify, and reconstitute themselves through a multi-directional interactive process 
that is facilitated by the nodes (but is by no means reliant on the nodes). 
‘Nodes’ are notional intersections at which actors and artefacts come together 
to discuss, assess and perhaps adjust or correct the environment; these intersections 
may be geographic or temporal, institutional and ongoing, or intermittent or ad hoc.  
They serve as opportunities for actors to (re)shape the environment or constituent 
elements thereof in a proactive and productive way. 
The similarities of the above model to a living cell are apparent, and 
appropriately so, for, like a cell, a healthy social/science environment is a living, 
thriving thing which must be nourished.  Generally, one can imagine the following: 
the specific subject – in this case stem cell and regenerative science – is like a cell 
membrane, forming a thin, porous conceptual layer which encircles the social/science 
environment; actors, like the larger organism, might be seen to encase the 
membrane/subject, injecting and receiving information and thereby helping to shape 
both the subject and the environment; artefacts are like endoplasmic reticulum, 
contributing directly and indirectly to the primary output of the environment – 
bioscience;  nodes are like mitochondria, generating the energy necessary to sustain or 
enhance the greater environment. Represented diagrammatically, a healthy 
environment might look as depicted in Diagram 1.13 
 
 
                                                 
13  Though an argument can be made that the boundaries between the Artefacts themselves and 
between the Artefacts and the Output should be closer and more blurred.  As previous scholarship has 
suggested, the separation between science and politics, for example, as distinct spheres of activity is 
not defensible.  Science shapes politics – offering issues, influencing debates, impacting on careers – 
and science is shaped by political agendas and values.  In short, knowledge in different walks of life 
develop together and influence each other.  As such, one could argue that the environment is not quite 
as ‘clean’ as suggested, but the Diagram is appropriate insofar as it highlights the mutual interactions 




Importantly, each artefact within the environment should be optimised if innovation 
opportunities are to be maximised (though weaknesses in one may be compensated 
for by aspects of the others).  In order to optimise each artefact, interested actors must 
be given action space, that is the physical, temporal and cognitive space to reflect on, 
discuss, and influence the structures, so that the best combination of structure 
strengths, shapes and roles can be found.  In short, communication and action space 
must exist not only at the nodes but within the artefacts themselves.  The fact is that 
the nodes, while dynamic and energy-giving, might not be integrated into the 
governance structure.  But the artefacts require some permanent space which offers 
opportunities for ongoing engagement so that confrontation can be transformed into 
collaboration and the environment itself can be influenced toward positive ends.  
Ultimately, each structure must afford interested actors space to critically assess the 
role and functioning of the structure itself, and to reform the structure and therefore 
the whole environment more generally, the primary aim being to improve science and, 
through science, society. 
 The question of whether the social/science environment is operating optimally 
– and therefore generating good science and scientific innovation (and perhaps also 
governance innovation) – is complex, requiring evidence from a range of actors and 
having reference to the policy objectives for the science in question.  For present 
purposes, the question is: Based on the evidence available, to what extent does the 
Argentine environment reflect this notional model? 
 
II. THE ARGENTINE CONTEXT: EVIDENCE AND THE 
SOCIAL/SCIENCE ENVIRONMENT 
 
At the outset, it might be conceded that there will be very few jurisdictions which 
meet the ideal social/science environment, either from an architectural perspective or 
from an outcome perspective (ie: consistently generating the best science in the most 
efficient manner).  Having said that, the evidence generated in the GET: Social 
Values Project, combined with scholarship on the Argentine science setting,14 
suggests that the Argentine social/science environment (in the bioscience context) is 
not particularly ‘healthy’.  Although select bioscience activity is internationally 
recognised and competitive,15 and although Argentina’s reproductive medicine 
services are second to none, we might suspect that the environment within which they 
work is sub-optimal with multiple interrelated and cascading blockages stemming 
from actor, artefact and node shortcomings.16  The following section confirms this by 
considering some of the evidence in relation to each major element of the model 
environment 
With respect to the relevant actors, there is evidence that: 
 
• the range of empowered actors in the bioscience environment is narrow (ie: 
there is little diversity in active stakeholders); 
 
• the representational possibilities of divergent actor viewpoints is uneven (ie: 
the formal dialogue is dominated by a few powerful institutions, most notably 
the Church);17 
 
• the space within which actors can (publicly) operate is confined (ie: there are 
few opportunities for interested actors to network and to present a (unified) 
counter-point to some of the formal narratives); and 
 
                                                 
14  See P. Kreimer and M. Lugones, supra, note 2, P. Kreimer, “Science and Politics in Latin 
America: The Old and the New Context in Argentina” (1996) 1 Science, Technology and Society 267-
289, P. Kreimer and M. Lugones, “Pioneers and Victims: The Birth and Death of Argentina’s First 
Molecular Biology Laboratory” (2003) 41 Minerva 47-69, F. Luna and A. Salles, “On Moral 
Incoherence and Hidden Battles: Stem Cell Research in Argentina” forthcoming in Developing World 
Bioethics, and more. 
15  In particular, one might take note of the activity being undertaken at the FLENI, Leloir 
Institute, Hospital Garahan and others. 
16  Note that the consequences of a persistently sub-optimal social/science environment can be 
inefficient use of, or diminishing availability of, science funds, decreasing quality of science and/or low 
levels of innovation, or weak public support of science and/or scientist migration to other jurisdictions, 
depending on what element of the environment is exerting negative impact. 
17  For more on the role of the Church, see F. Zegers-Hochschild, “Attitudes Towards 
Reproduction in Latin America: Teachings from the Use of Modern Reproductive Technologies” 
(1999) 5 Human Reproduction Update 21-25. 
• there is general public support for science and scientists but also high science 
illiteracy and a willingness by portions of the public to self-censor actual 
values and ideas in the face of strong oppositional voices. 
 
Specific responses in the GET: Social Values Project which reflect these findings are 
as follows: 
 
R5: [E]ach country should try to contribute to the debate … .  I don’t 
know the view of my country.  I have no idea.  I could guess, but I don’t 
know.  One group is very loud; that doesn’t mean that they are many 
because they shout so loud.  I would really like to know what my 
country’s people would like to say about this subject [stem cell 
research]. 
 
R11: … [P]eople here that make the law don’t take care of scientists’ 
opinions.  They consult other people who are [involved] with political 
groups, not good groups [interested in] law, ethics [or] research.  Here 
the influence of the Catholic Church is really, really important. 
 
R16: There is a wide gap between these: science, society and social 
conception of science.  Of the research we did last year, 50% didn’t 
understand ‘cryopreservation’ and 40% didn’t understand ‘gene 
therapy’; they collapse it into cloning and manipulation. … This is the 
reason why I consider that, in Argentina, people’s perception of science 
is important but uninformed. … I am afraid that with stem cells it will be 
the same. 
 
Another respondent (R15) stated that there had been a ‘buzz’ since US President 
Obama’s statement on stem cell research funding, but that voices remain isolated 
because the rigid position of the Catholic Church forces people to be quite cautious 
about how they approach science discussions. 
 Ultimately, the relationship (and particular power dynamic) between certain 
central actors (eg: the church, media and political elites) serves as a bottleneck, 
blocking other actors from a more active role within the social/science environment.  
Thus, many actors who are otherwise interested in this setting are (or certainly feel) 
disempowered and unable to access in meaningful ways the spaces within which 
discussions might be undertaken and important decisions might be made. 
In relation to the artefacts, two in particular were identified as deficient by 
respondents: the science policy/regulatory artefact and the existing 
technologies/techniques artefact.  With respect to the former, most of those 
interviewed reported an inability to shape science legislation or to steer legislation 
and/or regulation in a rational and positive direction.  For example: 
 
R11: Yes, [we need a law] but [a] rational [law].  I am afraid because in 
the past when the government [adopts] legislation about science—well 
not really good. … 
 
R15: It is very difficult to pass a logical law in [reproductive medicine] 
… which is a related field. … It is not only the Church, but also a lot of 
newspapers that are very controlling in the way they [present] abortion 
and [similar] topics. 
 
R16: There is no regulation.  We have discussed [fertility treatment 
regulation] since 1989 … but it hasn’t been made into law because [of] 
the ‘beginning of life’ debate.  It has made it impossible to regulate 
[this] work, for moral and religious reasons – I think it is more religious 
than moral. 
 
R20: To be honest, I am so sceptical of the possibility of regulating stem 
cell research that I totally understand why some people would much 
rather say, ‘let’s not start anything’ … . 
 
Another respondent (R5) shared the above frustration at the inability to shape good 
science regulation, but stated that scientists must form their own views about 
boundaries, and should (somehow) take part in any discussions which lead to a law. 
With respect to the latter artefact – existing technologies and techniques – 
respondents articulated a lack of space to openly and intelligently explore the 
possibilities (for Argentina) of existing technologies and techniques.  Technologies 
and practices are either consciously shuttered or hidden or, more often, simply not 
communicated to, or discussed within, the public (ie: science is performed behind 
closed doors and good science communication is not the norm).  One respondent 
(R14) stated that scientists are not comfortable with announcing their research or their 
findings publicly because of feared reactions based on misunderstandings of science, 
and the respondent analogised this silence – this aversion to confrontation – to that 
experienced around the issue of divorce, an issue which bubbled below the surface for 
many decades until it exploded in the 1960s.  One member of the Advisory 
Commission on Regenerative Medicine and Cellular Therapies stated that they tried 
to encourage an open debate on stem cell research in 2007/08, but many of the key 
actors were reluctant to do so because of concerns about negative attention.18  Such an 
atmosphere, which might be characterised as defensive and oppressive, is detrimental 
to science and scientists themselves, and makes it impossible to deploy existing 
technologies to their maximum benefit.19 
With respect to nodes, there have been and remain very few dynamic 
intersections of communication and creation.  The Argentine MOST (and its 
predecessor, the Science and Technology Agency) sponsored two international policy 
conferences, one in 2007,20 and one in 2008.21  Both of these were ad hoc, as was a 
subsequent interactive workshop co-hosted by the Argentine Advisory Commission 
                                                 
18  This member was not a respondent in the GET: Social Values Project but a member with 
whom the author had direct and ongoing communication. 
19  An example of uneven (and therefore unjust) deployment of existing technologies and 
techniques in Argentina is the deployment and availability of safe abortion practices.  Cutting edge 
technologies and techniques are available, and are sourced by some, but are unavailable to the majority 
of people, primarily the poor, because abortion is still illegal in Argentina. 
20  Argentine Science and Technology Agency, “Regulation of Clinical Research Involving Stem 
Cells”, 29-30 November 2007, Buenos Aires.  For a report on this, see S. Harmon, G. Laurie and F. 
Arzuaga, “Regulation of Clinical Research Involving Stem Cells: Towards the Construction of a 
Regulatory Model for Argentina – Learning from the Experiences of the UK” (2008), available at 
http://www.law.ed.ac.uk/ahrc/esrcvaluesproject/files/Report%20Nov%2007%20Stem%20Cell%20Wor
kshop.pdf. 
21  Argentine Advisory Commission on Regenerative Medicine and Cellular Therapies, “Second 
International Conference on the Regulation of Stem Cells and Human Tissue”, 14 October 2008, 
Buenos Aires. 
on Regenerative Medicine and Cellular Therapies and the GET: Social Values 
Project., which workshop was attended by some 40 invited participants.22  In the latter 
case, participants lamented the absence of a more regularised means of coming 
together to discuss issues and to network in this field.  One respondent (R16) 
reiterated this, stating that attendees at recent doctors’ meetings indicated that they 
would like to work in this area (ie: in stem cell science) and they would like to have 
more contact with other organisations, including international institutions.  The 
respondent also expressed a desire to discuss, work and learn in a more networked 
manner. 
Based on all of the above, the Argentine stem cell and regenerative science 
environment might be diagrammatically represented as in Diagram 2. 
 
 
                                                 
22  Argentine Advisory Commission on Regenerative Medicine and Cellular Therapies and GET: 
Social Values Project, “The Regenerative and Cellular Sciences: Values, Objectives and Issues for 
Implementation – An Interactive Workshop”, 18 August 2009, Buenos Aires.  For a report on this, see 
S. Harmon, “Regenerative Medicine Governance: Report of the Workshop on Governance Research 
Using Human Embryonic Tissue” (2009) 6:3 SCRIPTed 729-740. 
 
 
Note that certain actors, most notably the lay public and patient groups, are thin/weak 
or missing (or blacked out from a communications point of view).  Aside from the 
policy element, the policy/regulatory artefact is undernourished.  There is almost no 
relevant existing legislation/regulation,23 and the discursive space is largely closed 
down by powerful actors antagonistic to bioscience.  The existing technologies 
artefact is partially concealed through science community silence and a relatively low 
level of science literacy, which means that technologies which are already being used 
(albeit unevenly) are not having the shaping effect on the environment that they might 
otherwise have.  Although this was not addressed directly in the responses, the 
innovation systems artefact is not ideal (and is therefore represented as fragmented).24  
Finally, available nodes of communication and dynamism are few and are not yet well 
entrenched.  Such then is the general social/science environment in Argentina; a sub-
optimal environment the shortcomings of which include an inability to measure or 
cope with plurality as it relates to science trajectories or means of governing same, 
facts which are mostly apparent to many of the respondents in the GET: Social Values 
Project.25 
Is there capacity and a will to improve the social/science environment in 
Argentina?  Based on observed expertise and interview responses, the answer is 
clearly ‘yes’, and there are already some positive signs.  For example, the National 
Institute for Organ Donation and Transplantation (INCUCAI) is becoming a useful 
conduit of scientific information and technical guidance for (an admittedly narrow 
range of) interested actors, a fact suggested by several respondents.  More 
importantly, the MOST is evolving as an important site of information, action and 
motivation, as is the Advisory Commission on Regenerative Medicine and Cellular 
Therapies, which serves an important reflective or evaluative function.  The work of 
these bodies since 2007 has made at least one element of the first artefact – science 
and funding policy and science legislation/regulation – quite robust and 
internationally engaged, and this largely as a result of the efforts of the new Minister 
of Science, Líno Barañao,26 but even this space has been opportunistic and largely 
limited to science and policy elites. 
However, as is perhaps clear, the scope of the task facing the MOST and other 
interested stakeholders is substantial.  The remainder of the paper focuses on one 
element of the undertaking: legal reform (or action) within the policy/regulatory 
                                                 
23  Both the Prohibition on Human Cloning Research, Presidential Decree No. 200/1997 and the 
Transplantation Act 2007 are only peripherally relevant to this setting. 
24  For a critique of the innovation system artefact, see D. Chudnovsky, “Science and Technology 
Policy and the National Innovation System in Argentina” (1999) 67 CEPAL Review 157-176, C. 
Correa, “Argentina’s National Innovation System” (1998) 15 International J Technology Management 
721-760, K. Thorn, “Science, Technology and Innovation in Argentina” (2005), available at 
http://siteresources.worldbank.org/INTARGENTINA/Resources/ScienceTechnologyandInnovationinA
rgentina.pdf [accessed 22 February 2010], C. Morel et al., “Health innovation Networks to Help 
Developing Countries Address Neglected Diseases” (2005) 309 Science 401-403, and more. 
25  Put very succinctly, the interaction in Argentina of science, politics and society, the latter 
which is heavily and, from a rationalist’s point of view, negatively influenced by the church, is not an 
ideal recipe for supporting (cutting edge) science and channelling it towards socially approved and 
useful purposes.  The theoretical characterisations here are helpful for discussing their interaction and 
mutual reliance and for singling out aspects of an otherwise sometimes murky Argentine setting so that 
they can be considered in more manageable portions and thereby more carefully scrutinised. 
26  Several respondents singled out Minister Barañao as being a central figure, noting his 
particular experience and qualities as being important to this moment for science in Argentina. 
artefact. 
 
III. THE REGULATORY ARTEFACT: COPING WITH PLURALITY 
 
Action and actor space at one artefact can be very important not only for the 
development of that artefact (and its outputs) but also for the overall social/science 
environment.  More specifically, it has been suggested that action within and by the 
policy and regulatory artefact is vitally important to the science environment and to 
the beneficent potential of science: 
 
In democratic societies, technological development and application 
operates, so to speak, with a social licence – a licence which itself is 
subject to the overriding restraints of respect for human rights and 
human dignity.  Accordingly, it falls to politicians and regulators, and 
ultimately to the law, to set the limits of technological innovation, to 
coordinate the assessment and management of risk, to design procedures 
for public participation, and to set the terms of compensatory 
responsibility. … [I]t also falls to the regulators and to the law to 
establish a governance environment that is supportive of desirable 
technological innovation and that ensures that benefits are fairly 
shared.27 
 
In short, the convergence of diverse and novel technologies and their rapid 
penetration into the lived human experience, demands governmental action. 
The empirical evidence generated by the GET: Social Values Project suggests 
that Argentine stakeholders – at least those interviewed – desire to have some 
boundaries articulated for bioscience, particularly that in the medical setting.  Known 
boundaries, it was felt, would have at least two salutary effects.  First, they would 
limit scientists by making clear what ends and/or methods are deemed to be 
(in)appropriate after existing methods and trajectories had been considered rationally 
(ie: it would reduce the possibilities of mavericks damaging the science/research 
reputation and agenda).28  Second, they would empower scientists in a positive way 
by assuring them that all of their activities within that articulated sphere are defensible 
and need not be sheltered from public scrutiny (ie: it would encourage the unveiling 
of science without putting scientists on the defensive). 
However, although almost all respondents felt that government boundary-
setting (in particular) would be valuable, there was no consensus on how that 
boundary-setting might be achieved, and they did not all agree that formal regulation 
was essential.  In this regard, opinions fell broadly into four camps: 
 
• Camp 1 – No Legislation: It is too early for legislation in the stem cell setting 
(R7).  Alternatively, legislation ought to be avoided because the tendency in 
Argentina is to ban and pass bad laws (R16).  It might be better for this area to 
first be quietly overseen by a regulatory committee under the Ministry of 
Science or Health so some oversight and advice can be offered as the field 
develops, and any furore is avoided (R21). 
                                                 
27  R. Brownsword and H. Somsen, “Before We Fast Forward – A Forum for Debate” (2009) 1 
Law, Innovation & Technology 1-73, at 2. 
28  Returning to the social/science environment and the cell metaphor, unchecked science can 
easily go out of control and/or lose social utility, and might be seen as cancer. 
 
• Camp 2 – Narrow Legislation: A stem cell-specific law is important because 
of the socially important issues thrown up by this research (R5, R10, R11, 
R14, R17, R19). 
 
• Camp 3 – General Research Legislation: Stem cell practices and issues are 
shared with other research and medical practices and techniques so a general 
medical research law is more useful, under which technique-specific 
regulations might be drafted by the executive on an as-needed basis (R1, R4, 
R6, R8, R18). 
 
• Camp 4 – General Medical Legislation: It is much more important to regulate 
the clinical setting than basic research; the safety of the patient is the most 
important element currently missing from the Argentine biomedical regulatory 
setting so it would be better to have a medical law (R3, R12, R15). 
 
In short, and potentially compounding the confusion and dissatisfaction caused by the 
existing legislative and regulatory silence from the policy/legislation artefact, there 
was a plurality of opinions as to how this artefact (or bodies within it) should respond 
and shape itself with respect to science boundary-setting, and there was a scepticism 
as to whether the artefact could shake itself into action and set a course that engaged 
with this plurality (and other pluralities that might arise). 
Given this plurality (on both the role of law and the shape/nature of publicly 
set boundary-setting for science) – a plurality which we might assume will be 
reproduced across society29 – it remains to be determined how Argentine 
policymakers might respond.  How might these very diverse (indeed contradictory) 
opinions be taken into account and (at least some of them) be put into action?30  That 
is a big question for another time, and one dependent on a broader base of evidence 
than presently exists, but the outlook is not wildly encouraging.  Some preliminary 
observations supported by the evidence are as follows: 
 
• The present manifestation of the broad Argentine social/scientific 
environment, with its uneven access to voice and its few nodes for open 
public debate, seems ill-suited to exploring a plurality of science and 
boundary opinions in a constructive manner, and less suited to encouraging a 
negotiated narrowing of options such that action which is generally supported 
can be taken. 
 
• Similarly, the potential of the policy/regulatory artefact to address a plurality 
of opinion in relation to either science boundaries or, more importantly, 
                                                 
29  Though we should be cautious about extrapolating too much from respondent areas of 
agreement (eg: that science is beneficial and should be facilitated) and disagreement (eg: on legal 
responses), it is reasonable to assume that inclusion of a wider range of stakeholders (eg: interested 
segments of the public) will result in even greater plurality, not only on the legal element of the 
policy/regulatory artefact, but, perhaps more importantly, on the bioscience endeavour more generally, 
where we might expect some very deep divisions on issues of whether to pursue stem cell research, 
how to apply stem cell research outputs, and therefore how to regulate activity in this field. 
30  Given the plurality of opinion which we can assume exists in Argentina with respect to stem 
cell and regenerative science more generally, and given the problems that the current socio-legal 
context is creating, I would suggest that this particular plurality is indeed one that should be serious 
considered, actively engaged with, and eventually acted upon, one way or another. 
methods for articulating and narrowing the plurality and then enforcing the 
boundaries ultimately agreed (ie: for shaping the artefact itself) seems 
seriously constrained due to a shortage of meaningful (and entrenched) policy 
discussion nodes and existing legislative fallowness. 
 
• The possibility of the best placed and best suited actors in the subject 
environment (eg: the MOST and Ministry of Health) adopting a pragmatic but 
explicit (as opposed to pragmatic but veiled or partially hidden) course which 
legally entrenches bioscience innovation facilitation seems remote.31 
 
Argentina might do well to look at what other jurisdictions have done when 
confronted with new technologies and social uncertainty.  Some 30 years ago, the UK 
formed the Committee of Inquiry into Human Fertilisation and Embryology, which 
reflected upon and undertook extensive public consultation about reproductive 
clinical medicine and related research, knowing full well that a central question was 
the value to be given to human life and how the law should respond.32  On the issue of 
plurality, (then) Dame Mary Warnock reported that the Committee encountered very 
diverse and strongly held opinions and understood that it would be impossible to 
satisfy all interested parties.33  As such, a majority of the Committee settled on a 
compromise between sacralisation and instrumentalisation of the embryo, concluding 
that the human embryo had a “special status” entitling it to “some protection in law”, 
and it advanced the view that, while the law must not outrage the feelings of too many 
people, it could not possibly reflect the feelings of them all.34 
Of course, while it can be useful to explore successful policy practices, 
transplanting them from one jurisdiction to another is not necessarily the answer, 
especially where the cultural affinity of the receiving jurisdiction for the practice 
might be assumed be weak.  Even if the Argentine appetite is weak for a lightning-rod 
body seeking public evidence and offering guidance, philosophical and legal, one gets 
the sense that Argentina’s new MOST is open to ideas for improving both the actor 
space within the policy/regulation artefact as well as the general environment.  
Having said that, it seems unlikely that Argentine policymakers will, at this stage, 
take such a bold step as to, on the one hand, publicly acknowledge the (presumed) 
plurality of opinion on stem cell and regenerative science and the multiple courses 
open to it from a governance point of view (ie: the plurality of pluralities), and, on the 
other hand, explicitly define a course for acceptable uses of human tissue (including 
embryos) in stem cell and regenerative science.  The existing social/science 
                                                 
31  A key assumption being made here – and in developed country legal circles more generally – 
is that the policy/regulatory artefact should encourage and facilitate science innovation: see R. 
Brownsword and H. Somsen, supra, note 27, and S. Harmon, “Ambition and Ambivalence: 
Encouraging a ‘Techno-Science Culture’ in Argentina Through Engagement and Regulatory Reform” 
submitted. 
32  Established in July 1982, the Warnock Committee had the remit of: considering recent and 
potential developments in medicine and science related to human fertilisation and embryology; 
considering what policies and safeguards should be applied, including considering the social, ethical 
and legal implications of these developments; and making recommendations with a view toward 
legislation.  The Committee contained seven doctors/researchers, three lawyers, two social workers, a 
theologian, a health administrator and an entrepreneur.  It heard some 21 oral representations, 
considered evidence from hundreds of interested individuals and organisations, and received 695 letters 
and submissions from the public. 
33  M Warnock, A Question of Life: The Warnock Report on Human Fertilisation and 
Embryology (Oxford: Basil Blackwell, 1985) at 1. 
34  Ibid, at xvi and 63. 
environment, which is heavily influenced by the dominant features of the broader 
socio-cultural-political environment, makes this a politically costly undertaking, and 
one potentially damaging to the interests of science protagonists. 
That being said, there are recent Latin American examples of such bold moves 
being taken.  Here the experience of Brazil, a similarly Catholic country, might be 
instructive.  In March 2005, after years of campaigning by researchers and patient 
groups, the Brazilian Congress passed (by a vote of 352-60) the Biosafety Law.35  
Article 5 of that law allows the use of human embryos produced by IVF, if: 
 
1. the embryos have been frozen for more than three years; 
2. the embryos would be unlikely to survive if transferred to a woman;36 
3. the progenitors give consent; and 
4. they will not be used for therapeutic cloning. 
 
In May 2005, the then Attorney General filed a Direct Unconstitutionality Claim,37 
alleging that the constitution stipulates that life occurs at the moment of conception 
and Article 5 therefore contradicts the constitutional principle of the inviolability of 
life.  In April 2007, after some delay, the Brazilian Supreme Court held public 
hearings (for the first time in its history) during which it heard testimony from a range 
of experts.  On 29 May 2008, the 11-member Court ruled, by a vote of 6-5, that 
Article 5 was constitutional.  Throughout this period (pre-2005 to 2008), stem cell 
research suffered some uncertainty in Brazil (and stem cell projects had great 
difficulty finding funding),38 but by October 2008 the first Brazilian stem cell line had 
been announced.39  Also during this period, as a direct result of the legislative action, 
Brazil experienced intense information exchange and debate: 
 
The hearings at the Supreme Court demonstrated a democratic aspect of 
Brazilian society.  Rarely has Brazilian society discussed any aspect of 
science or public health with such an intensity.  Rarely have so many 
well-informed people expressed an opinion about a subject with legal, 
religious and scientific implications.  Never before have Brazilian media 
realised such a wide coverage of science communication in a short 
period of time.40 
 
Confirming scholarship in this arena,41 this Brazilian adventure demonstrates the 
central role of the mass media in the policymaking arena – as attention-influencer, 
issue-definer, symbol-creator, and opinion-shaper.  Indeed, it has been reported that 
the media’s explanations were essential to the approval of the law.42  Moreover, and 
                                                 
35  Law No. 11,105, 24 March 2005. 
36  This non-viability condition was defined in Decree No. 5,591, 22 November 2005, as those 
embryos with proven genetic alterations that prevent development due to lack of cleavage. 
37  Ação Directa de Inconstitucionalidade 3,510.  The subsequent Attorney General filed a 
supporting brief with the Supreme Court. 
38  M. Leite, “Stem Cell Research in Brazil: A Difficult Launch” (2006) 124 Cell 1107-1109. 
39  D. Diniz & D. Avelino, “International Perspective on Embryonic Stem Cell Research” (2009) 
43 Rev Saúde Pública 541-547. 
40  C. Jurberg et al., “Embryonic Stem Cell: A Climax in the Reign of the Brazilian Media” 
(2009) 18 Public Understanding of Science 719-729, at 727. 
41  See M. Nesbit & B. Lewenstein, “Biotechnology and the American Media: The Policy 
Process and the Elite Press, 1970-1999” (2002) 23 Science Communication 359-391. 
42  C. Jurberg et al., supra, note 40. 
very importantly, while it presented evidence on both sides of the debates, it did not 
bow to religious pressures but rather, at least in its selection of letters to be published 
and settings from which to broadcast, it evinced a bias reflective of public opinion as 
polled shortly before the Supreme Court’s decision.43 
The Brazilian experience demonstrates that, even in Latin American 
jurisdictions where the conservative Catholic Church has significance political and 
social influence, there is scope to fundamentally alter a key artefact (the 
policy/regulation artefact and its outputs) and thereby reform the whole social/science 
environment, and to do so by making morally-pregnant bioscience debates public and 
taking proactive steps to facilitate biosciences through law.  It also suggests that doing 
so will inevitably be difficult and socially disruptive, but not necessarily damaging to 
science institutions and pursuits.  Of course, much will undoubtedly depend on (1) the 
relative strengths of leading protagonists (eg: political and policy leaders) and 
resisting institutions (eg: the Church), (2) the willingness of supporting institutions 
(eg: eminent science bodies and academic institutions) to strongly engage, and (3) the 
responsibility and fairness of the media, which is generally recognised as a critical 
actor (ie: it must be prepared to reflect widely held social values for which there is 
some empirical base).  One of the benefits of country-based studies like the GET: 
Social Values Project is to begin to provide that evidence base.44 
In the absence of systemic or overt reform in Argentina, at least in the short 
term, one wonders whether the regulation of stem cell and regenerative science might 
best be achieved ‘through the back door’, as outlined by R21 in Camp 1 above.  The 
approach suggested is not exactly ‘status quo’ because it envisions the formation of a 
specialised committee that advises scientists and reviews protocols put to it; it would 
be more proscriptive than the existing Advisory Commission on Regenerative 
Medicine and Cellular Therapies, which advises primarily upward, not outward.  Such 
a body would probably be welcomed by the science community and pro-science 
publics insofar as it is flexible and helps to gradually develop regulatory capacity 
while building science momentum. 
On the negative side, such an approach would inevitably be characterised by a 
distinct lack of clarity around boundaries and limits on acceptable behaviour, and by 
weak oversight and enforcement (ie: it would permit malfeasance and leave both it 
and misfeasance largely unpunished).  Additionally, scientists who feel more secure 
undertaking their work quietly and anonymously would not be encouraged to open 
themselves and their work to public scrutiny any more than at present.  Finally, it 
                                                 
43  A January 2008 survey of Public Opinion Research Institute of Brazil (IBOPE) demonstrated 
that 75% of a 1,863 person sample (all between the ages of 16 and 70, and 1,230 of whom claimed 
Catholic membership) were in favour of embryonic stem cell research.  A television poll reported that 
66.7% of respondents were in favour of the use of embryonic stem cells, and letters to O Globo, a 
widely circulated newspaper, indicated a 64.7% favourable rate for stem cell research: C. Jurberg et al., 
ibid. 
44  The value of country-based studies has been noted by such luminaries as Sheila Jasanoff: see 
S. Jasanoff, “Controlling Biotechnology: Science, Democracy and ‘Civic Epistemology’ – Review 
Symposium” (2008) 17 Metascience 177-198.  While acknowledging the importance of international 
institutions and “global socio-technical imaginaries spawned around biotechnology”, she rightly asserts 
that politics, including science and technology politics, are local.  If one wishes to influence sci-tech 
trajectories or boundaries, one engages national institutions.  Thus, while international values and 
principles and international discourses are critical, possibilities for action are often (sometimes 
exclusively) national.  This makes country studies (and comparative country studies) valuable, often 
beyond the subject country, and this is certainly the case for Latin American countries.  While they are 
by no means homogenous, they share a lot of socio-economic and cultural features, making one 
relevant to another. 
would fail to address the hypocrisy lamented so strongly: 
 
R13 (Translator): He is saying that we of course have the capacity [to 
have a debate on stem cell research].  We are sincere but there is 
hypocrisy.  We have a tremendous struggle to manage every day … so 
starting to make the circle of information increase [is important]. 
 
Similarly, R15 expressed a need for more honesty in science settings; currently 
people say one thing but do another, or do something and say nothing at all, a 
hypocrisy which is perpetrated within the legislative, the scientific, and the public 
settings.45 
 The bottom line remains that most respondents are desirous of, and prepared 
for, something to happen in the Argentine policy/regulation artefact, and they 
generally hope that it is rational and sensitive to social and science needs, even if they 
diverge somewhat on what they feel is the best way forward from a policy or 




I have argued that the best science is developed at the nexus of three interacting and 
co-producing artefacts within a more diffuse but positive social/science environment 
which includes publicly acknowledged science/knowledge needs and desires.  Where 
these artefacts are open, dynamic and relatively harmonious, the best science is most 
likely produced.  Drawing on a variety of sources, including empirical evidence, I 
have also argued that the Argentine model is not at all optimal: its actors are too 
unevenly empowered; its artefacts are either underdeveloped (the policy/regulatory 
artefact), or veiled (existing technologies), or fragmented (the innovation systems 
artefact); and its nodes are ad hoc and weakly action-guiding.  Finally, focussing on 
the science policy/regulation artefact and the actor space in relation thereto, I have 
argued that there is a plurality of opinions amongst elite stakeholders with respect to 
how best to proceed in relation to stem cell and regenerative science. 
Through this undertaking, the reader will have (hopefully) gained a better 
understanding of the complexities of the social/science environment and of the 
encouragement of innovation therein, and, more centrally, of Argentina’s position in 
comparison to the model environment, as well as of some of the key issues facing 
Argentina, one of the most important of which is plurality.  Of course, exposing this 
plurality is important but insufficient. given the incapacity of the Argentine 
social/science environment and bioscience policy/legislation artefact to measure this 
plurality or to cope with it in a constructive manner, in part because of an absence of 
actor space therein.46 
Having been put on notice that plurality (or a particular plurality) exists, it 
behooves actors (including Argentine policymakers and researchers interested in 
Argentina) to expand the evidence base, measure plurality more accurately, and 
respond to it practically and rationally.  A next important step may be to solicit 
thoughtful value evidence from other important stakeholders such as Church and 
media representatives and publics, and then to ease cautiously into a more active 
public engagement programme sponsored by the MOST, the Ministry of Health, and 
                                                 
45  See also the discussion in F. Luna & A. Salles, supra, note 14. 
46  Related to this, neither the credibility of science nor the aspirations of publics for science can 
be accurately gauged in Argentina 
interested academic institutions.47  The bottom line is that Argentina would do well to 
fashion a bioscience regulatory framework worthy of the scientists currently plying 
their trade in Argentina – they and the legacy they are fulfilling deserve no less. 
It has been argued that political cultures (and we might say social/science 
environments) manifest in the routinized ways that knowledge is produced, 
disseminated, evaluated and deployed in society.48  By creating the MOST, Argentina 
has begun to shift the boundaries of science and politics and thereby alter its political 
culture (and social/science environment).  However, a positive and enduring 
reshaping, as demonstrated by Brazil (which is still consolidating after a major shift), 
requires courage and the participation of publics, particularly in a democracy where 
science is part of a nation-building project or national re-imagining.49  As hinted at by 
recent evidence,50 one might discover greater consensus than formal dialogues to date 
have suggested, and therefore greater scope to facilitate the scientific and regulatory 
work being pursued in Argentina. 
                                                 
47  The ultimate goal being to reform the science policy/legislation artefact and/or its primary 
relevant instruments, or both, thereby improving the relevant institutions, the broader artefact and, 
ultimately, scientific outputs and uptake. 
48  S. Jasanoff, Designs on Nature: Science and Democracy in Europe and the United States (NJ: 
Princeton U Press, 2005). 
49  This is certainly the case in Argentina, as it was in the UK and the US: see S. Jasanoff, ibid. 
50  See L. Vaccarezza, C. Polino and M. Fazio, “Measuring Public Perception of Science in 
Ibero-America: The RICYT/OEI’s Study and Argentina’s National Survey” in B. Bonnmatí (ed.), 
Scientific Knowledge and Cultural Diversity: PCST-8 Proceedings, (Barcelona: Rubes Editorial, 2004) 
436-443, and G. Stekolschik et al., “Does the Public Communication of Science Influence Scientific 
Vocation? Results of a National Survey”, Public Understanding of Science, published online 13 July 
2009 and available at http://pus.sagepub.com/cgi/rapidpdf/0963662509335458v1 [accessed 15 
February 2010]. 
